Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
P.1
Description:
An ambiguous alphanumeric label that may identify a SARS-CoV-2 variant or denote a mathematical or scientific quantity, depending on context.
Primary topic:
SARS-CoV-2 and COVID-19 Research (48%)
Related topics:
SARS-CoV-2 and COVID-19 Research (48%),
SARS-CoV-2 detection and testing (11%)
OpenAlex ID:
keywords/p-1
Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021
2021
·
Finlay Campbell
, Brett Archer
, et al.
·
Eurosurveillance
·
887
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
2021
·
Alison Tarke
, John Sidney
, et al.
·
Cell Reports Medicine
·
735
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
2021
·
Chang Liu
, Helen M. Ginn
, et al.
·
Cell
·
729
PDF
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
2021
·
Salim S. Abdool Karim
, Tulio de Oliveira
·
New England Journal of Medicine
·
728
PDF
SARS-CoV-2 Variants in Patients with Immunosuppression
2021
·
Lawrence Corey
, Chris Beyrer
, et al.
·
New England Journal of Medicine
·
453
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
2022
·
Kathryn Westendorf
, Stefanie Žentelis
, et al.
·
Cell Reports
·
432
PDF
N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
2021
·
Fang Tian
, Bei Tong
, et al.
·
eLife
·
417
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
2021
·
Angela Choi
, Matthew Koch
, et al.
·
Nature Medicine
·
391
PDF
The variant gambit: COVID-19’s next move
2021
·
Jessica A. Plante
, Brooke M. Mitchell
, et al.
·
Cell Host & Microbe
·
341
PDF
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
2021
·
Tjede Funk
, Anastasia Pharris
, et al.
·
Eurosurveillance
·
290
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2
2021
·
Chantal B. F. Vogels
, Mallery I. Breban
, et al.
·
PLoS Biology
·
244
PDF
Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
2021
·
Dan H. Barouch
, Kathryn E. Stephenson
, et al.
·
New England Journal of Medicine
·
236
PDF
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
2021
·
Carolina Lucas
, Chantal B. F. Vogels
, et al.
·
Nature
·
229
PDF
SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
2022
·
Suresh Thakur
, Shalitha Sasi
, et al.
·
Frontiers in Medicine
·
183
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
2021
·
Sindhu Ramesh
, Manoj Govindarajulu
, et al.
·
Vaccines
·
176
PDF
Definitions of Sobolev classes on metric spaces
1999
·
Bruno Franchi
, Piotr Hajłasz
, et al.
·
Annales de l’institut Fourier
·
173
PDF
ON THE NORMAL NUMBER OF PRIME FACTORS OF p-1 AND SOME RELATED PROBLEMS CONCERNING EULER'S ø-FUNCTION
1935
·
PAUL ERDóS
·
The Quarterly Journal of Mathematics
·
172
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
2021
·
Daniele Focosi
, Fabrizio Maggi
·
Reviews in Medical Virology
·
158
PDF
Interferon resistance of emerging SARS-CoV-2 variants
2022
·
Kejun Guo
, Bradley S. Barrett
, et al.
·
Proceedings of the National Academy of Sciences
·
151
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
2021
·
Saya Moriyama
, Yu Adachi
, et al.
·
Immunity
·
144
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
2022
·
Catherine J. Reynolds
, Joseph M. Gibbons
, et al.
·
Science
·
140
PDF
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients
2021
·
Yuanling Yu
, Meiyu Wang
, et al.
·
Signal Transduction and Targeted Therapy
·
132
PDF
The Emerging Concern and Interest SARS-CoV-2 Variants
2021
·
Edyta Janik
, Marcin Niemcewicz
, et al.
·
Pathogens
·
122
PDF
Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants
2021
·
Vladimir A. Gushchin
, Inna V. Dolzhikova
, et al.
·
Vaccines
·
121
PDF
Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
2021
·
Zaixing Jia
, Wenping Gong
·
Journal of Korean Medical Science
·
101
Show more works
View as search
Works count:
264
Citation count:
11,180
Year
Topic
Type